
Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Interests: Ovarian Cancers; uterine cancers; vulvar and vaginal cancers; rare gynecological cancers
Interests: NK cells; immunotherapy; programmed cell death protein 1; ovarian cancer; gynecologic cancers; tumor resistence; metastasis; microRNA; biomarker discovery
Interests: apoptotic bodies; extracellular vesicles; innate immunity; host defense peptides; antimicrobial peptides; cell death; cell clearance; apoptosis
Interests: pharmacoepidemiology, pharmacovigilance, drug-utilisation, pharmacoeconomy, health economy, real-world data, registries, care-pathway, target population to new drugs, health policy
Interests: epigenetics; methylation; cancer biomarkers
Interests: cachexia; muscle atrophy; weakness; skeletal muscle; c2c12 myotubes; Bone resorption; bone-muscle crosstalk; chemotherapy
Interests: breast cancer; prostate cancer; metastasis; circulating tumor cells; liquid biopsy; cancer cell biology; tumor microenvironment
Interests: neuroendocrine cancers; cancer biology; miRNAs; vitamina D; target therapy; drug resistance; hepatocellular carcinoma
Interests: acute leukemia; flow cytometry; minimal residual disease; hematopoietic stem cells; leukemia stem cells; hematopathology; myelodysplastic; myeloproliferative diseases; immunotherapy in hematology; NK cells innate immunity
Interests: micrornas; non-coding RNAs; cancer stem cells; pediatric brain tumors; hedgehog pathway
2. Department of Oncologic Dermatology, Elias Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Interests: dermatology; skin cancers; psoriasis; atopic dermatitis; bullous diseases; cutaneous lympphomas; chronic wounds; dermatologic surgery
Interests: Myeloid neoplasms; DNA Damage; DNA repair; DNA repair inhibitors; DNA damage response; dna damage signaling; irradiation
Interests: melanoma, mTOR and MAPK pathways
Interests: biostatistics; design of experiments; cancer, biomarkers; preclinical research; systems biology
Interests: head and neck cancer; HNSCC; thyroid cancer; cutaneous squamous cell cancer; immunotherapy; PD-L1 inhibitors; next generation sequencing; tDNA; ctdna; biomarkers
Interests: obesity; diabetes; gut microbiotia; probiotics; mucins; pancreatic cancer and colorectal cancer
Interests: cutaneous; conjunctival; vulvar and cervical melanoma; molecular biology; biomarkers; DNA methylation; vulvar cancer; cutaneous lymphomas
Interests: cathepsins; galectin; angiogenesis; tumour microenvironment; ovarian cancer; metastasis; cell signaling; nanomedicine in cancer; endothelial cell biology
Interests: colon and gastric cancers; drug delivery systems for gastroenteric cancers; exosomes and extracellular vesicles; wnt pathway
Interests: molecular genetics; cell signaling mechanisms; mammary gland development; breast cancer; Alzheimer's disease
2. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN 46617, USA
3. Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
Interests: chemoresistance in breast cancer; targeted therapy; epithelial polarity; APC tumor suppressor; mouse models
Interests: cancer cells; colorectal cancer; tams; endothelial cells; metastasis; EMT; cancer microenvironment; cell migration; microRNA
2. Department of Neuropathology, Heidelberg University Medical Center, 69120 Heidelberg, Germany
Interests: Brain Tumor; glioma; astrocytoma; Oligodendroglioma; isocitrate dehydrogenase; IDH; Inhibitor development; mouse tumor models
Interests: AKT; genomics; proteomics; cancer; oncology and hematology clinics
Interests: brain tumors; CNS tumors; drug design; computational modeling
Interests: extracellular vesicles; gel electrophoresis (1DE, 2DE, diagonal); glycoproteomics; kidney; lipidomics; proteomics; renal cell carcinoma; urine
Interests: cancer drug development; cancer prevention; epigenomics/epigenetics (deacetylase inhibition); dna damage/repair; dietary chemoprevention; colorectal cancer; small intestinal cancer; preclinical models of intestinal cancer; human translational studies and clinical trials
Interests: ADC drug transporters; breast cancer; breast cancer stem-like cells; cell migration; invasion and metastasis; chemokine receptors; chemoresistance; CXCR4 and CXCR2; LASP1
Interests: influence of microorganisms; cancer and metastasis
Interests: breast cancer; clinical trials; cancer registries; metastasis; recurrence; chemoprevention; EMT; cancer metabolism; health disparities